Bristol-Myers Squibb Says Phase 3 Trials of Sotyktu in Psoriatic Arthritis Meets Endpoints

Market Closed -
Other stock markets
|
Pre-market 08:58:56 am | |||
59.71 USD | +1.00% |
|
57.38 | -3.91% |
07:48am | Bristol Myers: EPS down 2% in Q4 | CF |
07:22am | Bristol-Myers Squibb's Q4 Non-GAAP Earnings Decline, Revenue Increases | MT |